Isoprenalina Labesfal

Isoprenaline Hydrochloride, the active ingredient in Isoprenalina Labesfal, is a beta‑adrenergic agonist presented as a sterile injectable solution for intracardiac, intramuscular, and intravenous use. It treats bradyarrhythmias, cardiac arrest, and heart block in acute care settings.

GNH USA supplies Isoprenalina Labesfal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Isoprenaline Hydrochloride is used in cardiovascular emergencies to stimulate β‑adrenergic receptors and improve cardiac function.

- Bradyarrhythmias: increases heart rate to restore normal rhythm. - Cardiac arrest: provides β‑adrenergic stimulation to support cardiac output during resuscitation. - Heart block: enhances atrioventricular conduction to improve heart rhythm.

Isoprenaline Hydrochloride may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Tachycardia: excessive increase in heart rate. - Palpitations: sensation of rapid or irregular heartbeat. - Tremor: involuntary muscle shaking. - Headache: mild to moderate pain in the head. - Nausea: feeling of sickness or urge to vomit. - Hyperglycemia: elevated blood glucose levels.

Serious or Rare Side Effects: - Arrhythmias: potentially dangerous irregular heart rhythms. - Myocardial ischemia: reduced blood flow to heart muscle. - Severe hypotension: dangerous drop in blood pressure. - Pulmonary edema: fluid accumulation in the lungs. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Cardiac arrest: worsening of cardiac function in rare cases.

When using Isoprenaline Hydrochloride, clinicians should observe specific safety measures.

- Cardiac monitoring: continuous ECG to detect arrhythmias. - Dose titration: adjust dose gradually based on hemodynamic response. - Contraindications: avoid in patients with severe tachyarrhythmias. - Drug interactions: review concomitant β‑blocker therapy. - Pregnancy and lactation: use only if benefits outweigh risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Isoprenaline Hydrochloride can interact with several medications, requiring careful management.

Major Interactions (Avoid): - β‑blockers: may blunt therapeutic effect and cause severe bradycardia. - Calcium channel blockers: increase risk of hypotension and heart block. - MAO inhibitors: potentiate cardiovascular stimulation.

Moderate Interactions (Monitor Closely): - Diuretics: may exacerbate electrolyte disturbances. - Antihypertensives: require blood pressure monitoring. - Digitalis glycosides: increase risk of arrhythmias. - Anesthetics: may enhance cardiac stimulation effects.